Status:
COMPLETED
Usefulness of Lidocaine in Oral and Maxillofacial Surgeries Under General Anesthesia for Pain Control After Operation
Lead Sponsor:
B.P. Koirala Institute of Health Sciences
Conditions:
Pain, Postoperative
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
This will be a randomized double blinded clinical study conducted in patients undergoing oral and maxillofacial surgery under general anesthesia. Lidocaine group will receive intravenous bolus 1.5 mg/...
Eligibility Criteria
Inclusion
- Adult patients 18-60 years of age
- Patients of ASA (American Society of Anesthesiologists) Class I or Class II (I- healthy with no systemic disease, II- mild systemic disease with no functional limitation) who require oral and maxillofacial surgeries under general anesthesia
Exclusion
- Refusal to give consent.
- Hypersensitivity or allergy to the study medication.
- ASA physical status III or more.
- Subjects with known severe hepatic or renal dysfunction or cardiac dysrhythmia or atrioventricular block.
- History of taking opioids or antiarrhythmic drugs within 1 week of surgery.
- History of drug or alcohol abuse
- History of psychiatric disorders.
- Patients requiring emergency surgery.
- Patients unable to comprehend pain assessment
Key Trial Info
Start Date :
March 28 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 27 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03479320
Start Date
March 28 2018
End Date
March 27 2019
Last Update
April 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
B. P. Koirala Institute of Health Sciences
Dharān, Nepal, 34464